Research Article

[Retracted] LAG3 and PD1 Regulate CD8+ T Cell in Diffuse Large B-cell Lymphoma Patients

Table 1

DLBCL patient characteristics of the study.

CharacteristicsLevel/typeValue

Sex (%)F18 (46.2)
M21 (53.8)
Age (mean (SD))59.8 (13.8)
Diagnosis (%)DLBCL39 (100.0)
FishDouble hit2 (5.1)
Therapy (%)CHOP1 (2.6)
R-CHOP/CDOP36 (92.3)
R-DA-EPOCH2 (5.1)
Response in third course (%)CR20 (51.3)
PD2 (5.1)
PR12 (30.8)
SD2 (5.1)
Unknown3 (7.7)
Response in sixth course (%)CR25 (64.1)
PD4 (10.3)
PR2 (5.1)
SD1 (2.6)
Unknown7 (17.9)
Stage (%)I2 (5.1)
II7 (18.0)
III3 (7.7)
IV27 (69.2)
IPI (%)00 (0)
13 (7.7)
24 (10.3)
32 (5.1)
44 (10.3)
55 (12.7)
aaIPI (%)03 (7.7)
14 (10.3)
29 (23.0)
34 (10.3)
41 (2.6)
Increased LDH (%)21 (53.8)
Increased ESR (%)20 (51.3)
Increased CRP (%)14 (35.9)
Increased β2MG (%)20 (53.8)